Prostate Cancer
Conditions
Interventions
RARP-group:Conventional RARP (Fluorescence-Free Navigation)
PSMA-group:Preoperative injection of 68Ga-P3 fluorescent probe and intraoperative robotic-assisted radical prostatectomy (RARP) under fluorescence navigation
Sponsors
Peking University First Hospital
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. Prostate cancer patients who need robot-assisted radical prostatectomy (RARP). 2. Confirmed by traditional imaging examination (bone scintigraphy, CT or MRI) or PET/CT as M0 (no distant metastasis), pelvic lymph node metastasis (N1) is allowed to enroll 3. Age>=18 years old and <=80 years old 4. Sign the informed consent form
Exclusion criteria
Exclusion criteria: 1. Refusal to sign informed consent or inability to cooperate with the study 2. Unable to tolerate PET/CT or RARP 3. Previous treatment for prostate cancer: Systemic therapy (e.g., ADT >for 2 months, endocrine therapy, chemotherapy, immunotherapy, etc.) for 2 months Local therapies (eg, pelvic radiation therapy, surgery) 4. Other malignant tumors within the past 5 years or at the same time
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Surgical Margin; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperation of PSA; | — |
Countries
China
Contacts
Public ContactLi Xuesong, Shen Cheng
Peking University First Hospital
Outcome results
None listed